FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1965790874> ?p ?o ?g. }

• W1965790874 endingPage "113" @default.
• W1965790874 startingPage "105" @default.
• W1965790874 abstract "Pemphigus vulgaris (PV) is an autoimmune blistering disease caused by IgG autoantibodies against desmoglein 3 (Dsg3). We have recently developed an active disease mouse model for PV by adoptive transfer of splenocytes from Dsg3−/− mice. The purpose of this study was to determine the role of CD40/CD154 interaction in the pathogenic antibody production and development of the disease in PV model mice. When anti-CD154 monoclonal antibody (mAb) was administered to recipient mice prior to adoptive transfer, anti-CD154 mAb almost completely blocked the anti-Dsg3 IgG production and prevented blister formation. The blockade of CD40/CD154 interaction induced tolerance against Dsg3 as the suppression of antibody production was observed through day 70, and it was maintained even after challenge by immunization with recombinant mouse Dsg3 or by adoptive transfer of immunized Dsg3−/− splenocytes. Furthermore, the tolerance to Dsg3 was transferable because cotransfer of splenocytes from anti-CD154 mAb-treated mice and naïve Dsg3−/− splenocytes significantly suppressed anti-Dsg3 IgG production in recipient mice. In contrast, when anti-CD154 mAb was injected after the mice had developed the PV phenotype, no significant suppression of the production of anti-Dsg3 IgG was observed. These findings indicate that the CD40/CD154 interaction is essential for the induction of pathogenic anti-Dsg3 IgG antibodies and that antigen-specific immune-regulatory cells induced by anti-CD154 mAb would hold a therapeutic option for autoimmune diseases. Pemphigus vulgaris (PV) is an autoimmune blistering disease caused by IgG autoantibodies against desmoglein 3 (Dsg3). We have recently developed an active disease mouse model for PV by adoptive transfer of splenocytes from Dsg3−/− mice. The purpose of this study was to determine the role of CD40/CD154 interaction in the pathogenic antibody production and development of the disease in PV model mice. When anti-CD154 monoclonal antibody (mAb) was administered to recipient mice prior to adoptive transfer, anti-CD154 mAb almost completely blocked the anti-Dsg3 IgG production and prevented blister formation. The blockade of CD40/CD154 interaction induced tolerance against Dsg3 as the suppression of antibody production was observed through day 70, and it was maintained even after challenge by immunization with recombinant mouse Dsg3 or by adoptive transfer of immunized Dsg3−/− splenocytes. Furthermore, the tolerance to Dsg3 was transferable because cotransfer of splenocytes from anti-CD154 mAb-treated mice and naïve Dsg3−/− splenocytes significantly suppressed anti-Dsg3 IgG production in recipient mice. In contrast, when anti-CD154 mAb was injected after the mice had developed the PV phenotype, no significant suppression of the production of anti-Dsg3 IgG was observed. These findings indicate that the CD40/CD154 interaction is essential for the induction of pathogenic anti-Dsg3 IgG antibodies and that antigen-specific immune-regulatory cells induced by anti-CD154 mAb would hold a therapeutic option for autoimmune diseases. desmolgein3 monoclonal antibody recombinant mouse Dsg3 intraperitoneal pemphigus vulgaris" @default.
• W1965790874 created "2016-06-24" @default.
• W1965790874 creator A5009626774 @default.
• W1965790874 creator A5010698054 @default.
• W1965790874 creator A5038635442 @default.
• W1965790874 creator A5071614936 @default.
• W1965790874 creator A5073569021 @default.
• W1965790874 creator A5077507524 @default.
• W1965790874 creator A5078739339 @default.
• W1965790874 creator A5084178900 @default.
• W1965790874 creator A5086853057 @default.
• W1965790874 date "2006-01-01" @default.
• W1965790874 modified "2023-10-17" @default.
• W1965790874 title "Tolerance Induction by the Blockade of CD40/CD154 Interaction in Pemphigus Vulgaris Mouse Model" @default.
• W1965790874 cites W1481803988 @default.
• W1965790874 cites W1514664819 @default.
• W1965790874 cites W1602264889 @default.
• W1965790874 cites W1675026965 @default.
• W1965790874 cites W1927348210 @default.
• W1965790874 cites W1932566429 @default.
• W1965790874 cites W1942869822 @default.
• W1965790874 cites W1969435259 @default.
• W1965790874 cites W1987968095 @default.
• W1965790874 cites W1995679262 @default.
• W1965790874 cites W2003661326 @default.
• W1965790874 cites W2004228931 @default.
• W1965790874 cites W2005945803 @default.
• W1965790874 cites W2008236686 @default.
• W1965790874 cites W2016821270 @default.
• W1965790874 cites W2029583250 @default.
• W1965790874 cites W2036321057 @default.
• W1965790874 cites W2039923083 @default.
• W1965790874 cites W2042441746 @default.
• W1965790874 cites W2050793959 @default.
• W1965790874 cites W2058876253 @default.
• W1965790874 cites W2065526075 @default.
• W1965790874 cites W2068488477 @default.
• W1965790874 cites W2073281335 @default.
• W1965790874 cites W2075709975 @default.
• W1965790874 cites W2076820280 @default.
• W1965790874 cites W2087812766 @default.
• W1965790874 cites W2089835279 @default.
• W1965790874 cites W2092144227 @default.
• W1965790874 cites W2094293975 @default.
• W1965790874 cites W2094800200 @default.
• W1965790874 cites W2095179395 @default.
• W1965790874 cites W2100989466 @default.
• W1965790874 cites W2114302659 @default.
• W1965790874 cites W2118184788 @default.
• W1965790874 cites W2126295850 @default.
• W1965790874 cites W2137268127 @default.
• W1965790874 cites W2149742356 @default.
• W1965790874 cites W2157037806 @default.
• W1965790874 cites W2160891647 @default.
• W1965790874 doi "https://doi.org/10.1038/sj.jid.5700016" @default.
• W1965790874 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16417225" @default.
• W1965790874 hasPublicationYear "2006" @default.
• W1965790874 type Work @default.
• W1965790874 sameAs 1965790874 @default.
• W1965790874 citedByCount "53" @default.
• W1965790874 countsByYear W19657908742012 @default.
• W1965790874 countsByYear W19657908742013 @default.
• W1965790874 countsByYear W19657908742014 @default.
• W1965790874 countsByYear W19657908742015 @default.
• W1965790874 countsByYear W19657908742017 @default.
• W1965790874 countsByYear W19657908742018 @default.
• W1965790874 countsByYear W19657908742019 @default.
• W1965790874 countsByYear W19657908742020 @default.
• W1965790874 countsByYear W19657908742021 @default.
• W1965790874 countsByYear W19657908742022 @default.
• W1965790874 countsByYear W19657908742023 @default.
• W1965790874 crossrefType "journal-article" @default.
• W1965790874 hasAuthorship W1965790874A5009626774 @default.
• W1965790874 hasAuthorship W1965790874A5010698054 @default.
• W1965790874 hasAuthorship W1965790874A5038635442 @default.
• W1965790874 hasAuthorship W1965790874A5071614936 @default.
• W1965790874 hasAuthorship W1965790874A5073569021 @default.
• W1965790874 hasAuthorship W1965790874A5077507524 @default.
• W1965790874 hasAuthorship W1965790874A5078739339 @default.
• W1965790874 hasAuthorship W1965790874A5084178900 @default.
• W1965790874 hasAuthorship W1965790874A5086853057 @default.
• W1965790874 hasBestOaLocation W19657908741 @default.
• W1965790874 hasConcept C154317977 @default.
• W1965790874 hasConcept C159654299 @default.
• W1965790874 hasConcept C163764329 @default.
• W1965790874 hasConcept C185592680 @default.
• W1965790874 hasConcept C189976730 @default.
• W1965790874 hasConcept C202751555 @default.
• W1965790874 hasConcept C203014093 @default.
• W1965790874 hasConcept C2779075594 @default.
• W1965790874 hasConcept C2779234475 @default.
• W1965790874 hasConcept C2781313415 @default.
• W1965790874 hasConcept C2781327288 @default.
• W1965790874 hasConcept C2909223747 @default.
• W1965790874 hasConcept C39347974 @default.
• W1965790874 hasConcept C55493867 @default.
• W1965790874 hasConcept C67326383 @default.
• W1965790874 hasConcept C71924100 @default.

• next